Tag Archives: BARDA

Jim Greenwood Op-Ed: Time to Fund Medical Countermeasures against Threats like Ebola

Jim Greenwood

On Friday, The Hill published an op-ed from BIO President and CEO Jim Greenwood calling on Congressional appropriators to fully fund federal biodefense programs, which partner with industry to develop medical countermeasures against Ebola as well as other threats like smallpox, anthrax, and botulism toxin. President Obama’s supplemental Ebola funding request last week asked Congress to appropriate $157 million in funding for BARDA and $238 million for the National Institutes of Health to support Ebola Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , ,

Nature Biotechnology: Outpaced by an outbreak

admin-ajax

The current issue of Nature Biotechnology contains an editorial on the response to the Ebola outbreak that is well-worth the read. The editors discuss some of the barriers which have slowed the development of Ebola medicines, including budgetary issues with federal programs designed to incentivize the development of medical countermeasures for threats like Ebola: We have no medicines to combat Ebola partly because of the time it takes to develop products—BARDA has been in existence Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

U-T San Diego Commentary: Lack of Preparedness to Ebola Is Symptom of Larger Disease

admin-ajax

Last week, the U-T San Diego published an op-ed by Betrand Liang, CEO of Pfenex Inc., a BIO member, arguing that our current lack of vaccines and therapies for Ebola is a symptom of a larger problem. That problem, Liang argues, is a lack of funding for critical biodefense programs which Congress passed in 2004 as a way to prepare us for biological agents like anthrax, smallpox, and Ebola, as well as chemical, radiological, and Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Delivering on Biotech’s Promise to Treat Anthrax, Smallpox, Ebola

Jim Greenwood

Thanks to federal biodefense programs that partner with industry to develop and stockpile medical countermeasures, each year America is better equipped to respond to potential biological, chemical, nuclear and radiological threats, BIO president and CEO Jim Greenwood says in a Roll Call op-ed published today. With recent anthrax and smallpox incidents at CDC and NIH labs,  which fortunately did not lead to any human exposure,  it’s worth taking a look at how we might respond Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO Calls for Adequate Funding of Vaccine and Biodefense Programs

Copyright sanofi pasteur

It’s budget time here in Washington, with appropriators in the House and Senate working overtime to craft a budget that can pass both chambers and keep our government funded for another year – not always the easiest of tasks. Here at BIO, we’ve been just as busy working to ensure that the FY 2015 budget contains adequate funding for a host of programs that encourage medical innovation, robust public health and emergency preparedness programs, and Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,